Before you apply to GlaxoSmithKline Patient Access Programs Foundation
Who to contact, what to include, deadlines, typical grant size and geographic focus are available with membership.
Private Foundation
GlaxoSmithKline Patient Access Programs Foundation
GlaxoSmithKline Patient Access Programs Foundation is a Private Foundation headquartered in Philadelphia, PA. Financial data from the 2025 filing: $868.1M revenue, $868.1M expenses, $70.2M total assets.
EIN: 200031992
Philadelphia, PA
Private Operating Foundations
NTEE: T23
Latest filing: 2025
Total Revenue$868.1M
Total Expenses$868.1M
Total Assets$70.2M
Grants Given0
Grant Total$4.5B
Filing Years2020–2025
Officers & Directors
Director
Anthony Scott Esposito
Director
Audrey Abernathy
Director
Court Horncastle
Director
Efthimios Petroutsas
Director
Enda Wiseman
Director
Erin Hufman Beetsch
Officer compensation and complete director data available with membership.
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $868.1M | $868.1M | $70.2M |
| 2024 | $1.1B | $1.1B | $85.3M |
| 2023 | $903.0M | $903.0M | $73.5M |
| 2022 | $784.9M | $784.9M | $63.6M |
| 2020 | $527.5M | $527.5M | $42.1M |
Between 2020 and 2025, reported annual revenue grew from $527.5M to $868.1M (+65%), with total assets most recently reported at $70.2M.
Interactive year-over-year charts and full filing details available with membership.